Nyxoah S A (NYXH)

Fri, 10 Jul 2026 19:02:52 -0400 - 2 days ago

Nyxoah Touts Genio U.S. Launch Traction, Reimbursement Stability at Investor Day

2026-07-09T10:20:21.000Z - 3 days ago

Nyxoah price target lowered to $2.85 from $4 at Baird

Jul 8, 2026, 10:00 AM EDT - 4 days ago

Nyxoah Transcript: CMD 2026

2026-07-07T20:15:51.000Z - 5 days ago

Nyxoah sees Q2 revenue EUR 7.7M

2026-07-07T20:15:29.000Z - 5 days ago

Nyxoah backs FY26 revenue view EUR 36M-EUR 40M

Tue, 07 Jul 2026 16:05:00 -0400 - 5 days ago

Nyxoah Announces Preliminary Results for the Second Quarter of 2026

Tue, 30 Jun 2026 16:30:00 -0400 - 12 days ago

Information on the total number of voting rights and shares

Mon, 29 Jun 2026 16:30:00 -0400 - 13 days ago

Publication relating to transparency notifications

Tue, 23 Jun 2026 16:05:00 -0400 - 19 days ago

Nyxoah to Host Investor Day in New York on July 8, 2026

Fri, 19 Jun 2026 16:30:00 -0400 - 23 days ago

Invitation to attend the extraordinary shareholders' meeting of the Company to be held on July 9, 2026

Wed, 17 Jun 2026 16:30:00 -0400 - 25 days ago

Publication relating to transparency notifications

Wed, 17 Jun 2026 16:05:00 -0400 - 25 days ago

Nyxoah Receives $15 Million from the European Investment Bank

2026-06-17T10:55:08.000Z - 25 days ago

Nyxoah price target lowered to $3 from $5 at Stifel

Wed, 10 Jun 2026 17:00:00 -0400 - 4 weeks ago

Information on the total number of voting rights and shares

Wed, 10 Jun 2026 16:30:00 -0400 - 4 weeks ago

$110 Million in Aggregate Financings to Accelerate Genio's U.S. Commercial Launch

Wed, 10 Jun 2026 16:05:00 -0400 - 4 weeks ago

Nyxoah Announces Closing of Underwritten Public Offering

2026-06-05T15:45:09.000Z - 5 weeks ago

Nyxoah S.A. trading resumes

2026-06-05T15:36:10.000Z - 5 weeks ago

Nyxoah 55.23M share Spot Secondary priced at $1.72

Fri, 05 Jun 2026 11:25:00 -0400 - 5 weeks ago

Nyxoah Announces Pricing of $95 Million Underwritten Public Offering

2026-06-05T13:57:42.000Z - 5 weeks ago

Nyxoah S.A. trading halted, news pending

2026-06-04T20:14:55.000Z - 5 weeks ago

Nyxoah announces offering of ordinary shares, no amount given

2026-06-04T20:05:10.000Z - 5 weeks ago

Nyxoah announces plan to transition to U.S.-based CEO

Thu, 04 Jun 2026 16:02:00 -0400 - 5 weeks ago

Nyxoah Announces Proposed Offering of Ordinary Shares

Thu, 04 Jun 2026 16:01:00 -0400 - 5 weeks ago

Nyxoah Enters New Chapter of Long Term Value Creation

May 26, 2026, 7:00 AM EDT - 6 weeks ago

Nyxoah Slides: Corporate presentation

Wed, 20 May 2026 16:30:00 -0400 - 7 weeks ago

Information on the total number of voting rights and shares

Wed, 20 May 2026 16:05:00 -0400 - 7 weeks ago

Nyxoah Welcomes the Flemish Investors Federation (VFB) at LégiaPark following Q1 2026 Results and U.S. Commercial Momentum

May 13, 2026, 8:15 PM EDT - 2 months ago

Nyxoah Transcript: Bank of America Global Healthcare Conference 2026

2026-05-13T11:14:11.000Z - 2 months ago

Nyxoah price target lowered to $7 from $9 at Piper Sandler

Tue, 12 May 2026 21:09:14 -0400 - 2 months ago

Nyxoah Q1 Earnings Call Highlights

2026-05-12T22:33:58.000Z - 2 months ago

Nyxoah reports Q1 EPS (EUR 0.37) vs. (EUR 0.60) last year

May 12, 2026, 4:30 PM EDT - 2 months ago

Nyxoah Earnings Call Transcript: Q1 2026

May 12, 2026, 4:30 PM EDT - 2 months ago

Nyxoah Earnings release: Q1 2026

Tue, 12 May 2026 16:05:00 -0400 - 2 months ago

Nyxoah Reports First Quarter 2026 Financial and Operating Results

2026-05-12T01:45:10.000Z - 2 months ago

Nyxoah downgraded to Hold from Buy at Stifel

INSP

Tue, 28 Apr 2026 16:05:00 -0400 - 2 months ago

Nyxoah to Release First Quarter 2026 Financial Results on May 12, 2026

2026-04-10T11:45:49.000Z - 3 months ago

Nyxoah price target lowered to $8 from $10 at Stifel

2026-03-23T10:36:07.000Z - 3 months ago

Nyxoah price target lowered to $4.62 from $5.87 at Baird

Fri, 20 Mar 2026 17:30:00 -0400 - 4 months ago

Publication relating to transparency notifications

2026-03-20T11:45:13.000Z - 4 months ago

Nyxoah price target lowered to $10 from $11 at Stifel

Mar 19, 2026, 4:30 PM EDT - 4 months ago

Nyxoah Earnings Call Transcript: Q4 2025

Mar 19, 2026, 4:30 PM EDT - 4 months ago

Nyxoah Annual report: Q4 2025

Mar 19, 2026, 4:30 PM EDT - 4 months ago

Nyxoah Annual report: Q4 2025

Mar 19, 2026, 4:30 PM EDT - 4 months ago

Nyxoah Earnings release: Q4 2025

2026-03-19T20:25:54.000Z - 4 months ago

Nyxoah reports Q4 EPS (EUR 0.59) vs. (EUR 0.46) last year

2026-03-19T20:25:46.000Z - 4 months ago

Nyxoah sees Q1 revenue up 25% vs. Q4

Thu, 19 Mar 2026 16:10:00 -0400 - 4 months ago

Nyxoah Reports Fourth Quarter and Full Year 2025 Financial and Operating Results

Mar 16, 2026, 8:40 AM EDT - 4 months ago

Nyxoah Transcript: Oppenheimer 36th Annual Healthcare MedTech & Services Conference

Fri, 13 Mar 2026 17:30:00 -0400 - 4 months ago

Publication relating to transparency notification

Wed, 11 Mar 2026 17:05:00 -0400 - 4 months ago

Nyxoah to Participate in the Oppenheimer 36th Annual Healthcare MedTech & Services Conference

Thu, 05 Mar 2026 16:05:00 -0500 - 4 months ago

Nyxoah to Release Fourth Quarter and Full Year 2025 Financial Results on March 19, 2026

2026-02-18T21:30:45.000Z - 5 months ago

Nyxoah signs MoU with Sheikh Shakhbout Medical City

Wed, 18 Feb 2026 16:05:00 -0500 - 5 months ago

Nyxoah Announces the Signature of a Memorandum of Understanding with Sheikh Shakhbout Medical City Hospital to Improve OSA Therapy Management and Accelerate Access to Genio in the Middle East

2026-01-29T13:35:17.000Z - 5 months ago

Nyxoah price target lowered to $11 from $12 at Stifel

Wed, 21 Jan 2026 16:05:00 -0500 - 6 months ago

Nyxoah Invests In Further Expanding Its Belgian Manufacturing Capacity To Support Its Worldwide Growth

Jan 15, 2026, 3:00 PM EST - 6 months ago

Nyxoah Transcript: 44th Annual J.P. Morgan Healthcare Conference

Fri, 19 Dec 2025 16:05:00 -0500 - 7 months ago

Nyxoah Announces Issuance of First Tranche of Convertible Bonds

Wed, 17 Dec 2025 01:05:00 -0500 - 7 months ago

Nyxoah Announces Commercial Launch of Genio® Breakthrough Therapy in the Netherlands

Dec 4, 2025, 1:30 PM EST - 7 months ago

Nyxoah Transcript: Piper Sandler 37th Annual Healthcare Conference

Thu, 27 Nov 2025 16:05:00 -0500 - 8 months ago

Nyxoah to Participate in the Piper Sandler 37th Annual Healthcare Conference

Wed, 26 Nov 2025 01:45:00 -0500 - 8 months ago

Nyxoah's Genio® Therapy Receives Significant 2026 Medicare Reimbursement Increases Under Final CMS Rule

Thu, 13 Nov 2025 16:36:00 -0500 - 8 months ago

Nyxoah Secures Financing Commitments of up to U.S. $77 Million to Drive U.S. Commercialization of Genio

Nov 13, 2025, 4:30 PM EST - 8 months ago

Nyxoah Earnings Call Transcript: Q3 2025

Nov 13, 2025, 4:30 PM EST - 8 months ago

Nyxoah Earnings release: Q3 2025

Nov 13, 2025, 4:12 PM EST - 8 months ago

Nyxoah Reports Third Quarter 2025 Financial and Operating Results

Nov 11, 2025, 9:20 AM EST - 8 months ago

Nyxoah Transcript: Stifel 2025 Healthcare Conference

Nov 3, 2025, 4:05 PM EST - 8 months ago

Nyxoah to Participate in the Stifel 2025 Healthcare Conference

Oct 30, 2025, 5:10 PM EDT - 9 months ago

Nyxoah to Release Third Quarter 2025 Financial Results on November 13, 2025

Oct 6, 2025, 1:00 AM EDT - 9 months ago

Nyxoah Announces First U.S. Commercial Patients Implanted with Genio® System

Sep 23, 2025, 4:10 PM EDT - 10 months ago

Nyxoah Provides an Update on Expanded Middle East Presence

Sep 15, 2025, 4:10 PM EDT - 10 months ago

Nyxoah Files Patent Infringement Lawsuit Against Inspire Medical Systems, Inc.

Sep 9, 2025, 5:35 PM EDT - 10 months ago

Nyxoah Transcript: Morgan Stanley 23rd Annual Global Healthcare Conference

Sep 4, 2025, 11:30 AM EDT - 11 months ago

Nyxoah Transcript: Cantor Global Healthcare Conference 2025

Sep 2, 2025, 4:30 PM EDT - 11 months ago

Nyxoah Announces Upcoming Investor Events

Aug 18, 2025, 4:30 PM EDT - 11 months ago

Nyxoah Earnings Call Transcript: Q2 2025

Aug 18, 2025, 4:30 PM EDT - 11 months ago

Nyxoah Earnings release: Q2 2025

Aug 18, 2025, 4:10 PM EDT - 11 months ago

Nyxoah Reports Second Quarter Financial and Operating Results

Aug 11, 2025, 1:00 AM EDT - 11 months ago

Nyxoah Announces Preliminary Results for the Second Quarter of 2025

Aug 8, 2025, 4:10 PM EDT - 1 year ago

Nyxoah Receives Approval from FDA for Genio® System for the Treatment of Obstructive Sleep Apnea

Jul 29, 2025, 4:30 PM EDT - 1 year ago

Nyxoah to Release Second Quarter 2025 Financial Results on August 18, 2025

Jul 28, 2025, 4:05 PM EDT - 1 year ago

Nyxoah's DREAM Pivotal Study Data Published in the Journal of Clinical Sleep Medicine

Jun 13, 2025, 1:00 AM EDT - 1 year ago

Invitation to attend the extraordinary shareholders' meeting of the Company to be held on July 2, 2025

May 28, 2025, 4:30 PM EDT - 1 year ago

Nyxoah to Present at the Jefferies Global Healthcare Conference

May 14, 2025, 8:00 AM EDT - 1 year ago

Nyxoah Earnings Call Transcript: Q1 2025

May 14, 2025, 8:00 AM EDT - 1 year ago

Nyxoah Earnings release: Q1 2025

May 14, 2025, 1:00 AM EDT - 1 year ago

Nyxoah Reports First Quarter Financial and Operating Results

May 9, 2025, 1:00 AM EDT - 1 year ago

Invitation to attend the annual and the extraordinary shareholders' meetings of the Company to be held on June 11, 2025